Cyclocarya paliurus extract and application thereof in preparation of anti-coronavirus drugs
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- WEST CHINA HOSPITAL SICHUAN UNIV
- Publication Date
- 2021-04-20
Smart Images

Figure 1 
Figure 2
Abstract
Description
technical field
[0001] The invention relates to the field of biomedicine, in particular to an extract of Cyclocarya paliurus and its use in preparing anti-coronavirus drugs. Background technique
[0002] There are currently 7 types of coronaviruses that can infect humans: HcoV-229E, HcoV-NL63, HcoV-HKU1, HcoV-OC43, Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), Middle East Respiratory Syndrome Coronavirus ( MERS-CoV), 2019 novel coronavirus (2019-nCoV, SARS-CoV-2). Among them, SARS-CoV-2 is a new type of β-coronavirus, which belongs to single-stranded RNA virus, which is highly infectious and generally susceptible to the crowd. Although there is a certain understanding of the epidemiology, clinical characteristics, diagnosis, treatment, and prognosis of the new coronavirus pneumonia caused by SARS-CoV-2, the treatment still cannot meet the clinical needs, and there is a lack of specific drugs. Still pretty grim.
[0003] Most of the existing antiviral drugs are...